Equities

QHSLab Inc

USAQ:QBB

QHSLab Inc

Actions
  • Price (USD)0.085
  • Today's Change-0.007 / -7.61%
  • Shares traded20.00
  • 1 Year change+142.86%
  • Beta-0.9391
Data delayed at least 15 minutes, as of Nov 06 2024 15:34 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

QHSLab, Inc. is a medical device technology and software-as-a-service (SaaS) company. The Company focuses on enabling primary care physicians (PCPs) to increase their revenues by providing them with tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures. The products that the Company provides its physician clients enables them to diagnose and treat patients with chronic diseases The Company is engaged in providing PCPs with the software, training and devices necessary that allow them to treat their patients using value-based healthcare, informatics and algorithmic personalized medicine. Its digital healthcare, clinical decision support and point of care solutions also support non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and are reimbursable to medical practice.

  • Revenue in USD (TTM)1.61m
  • Net income in USD-190.50k
  • Incorporated2021
  • Employees4.00
  • Location
    QHSLab Inc901 Northpoint Parkway, Suite 302WEST PALM BEACH 33407United StatesUSA
  • Phone+1 (929) 379-6503
  • Websitehttps://www.usaqcorp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
North America Frac Sand Inc0.00-226.72k300.13k3.00---------0.0034-0.00340.00-0.0122------0.00---5,915.30-----------193.66---16.94-----100.00--142.25------
China Health Management Corp.483.00k-25.60m446.30k56.00------0.924-1,378.45-1,378.4525.37-41.350.04251.161.498,625.00-190.82---395.01---2,014.49---4,486.13--0.0203-1,353.25----37.69---363.55------
SPO Global Inc838.00k-540.00k514.46k2.00------0.6139-85.99-85.99131.76-476.561.76-------113.56-305.39----31.1527.31-64.44-384.85---1.45-----17.09-15.1313.03------
Dental Patient Care America Inc476.00k-513.00k554.43k4.00------1.16-0.0215-0.01330.02-0.0305------119,000.00--------23.32---107.77-----3.25----51.11--32.14------
Novo Integrated Sciences Inc13.52m-24.33m687.87k127.00--0.0691--0.0509-1.38-1.380.79550.52250.38048.217.55106,432.80-68.51-29.43-113.88-35.6437.6839.59-180.11-110.250.2227-0.66790.2093--7.117.1759.77---22.73--
QHSLab Inc1.61m-190.50k939.83k4.00------0.5826-0.0199-0.01990.1649-0.03670.909731.8013.83403,272.50-10.74-51.17---197.3159.52---11.81-65.100.1152-0.2641.30--13.34--52.98------
Modern Mobility Aids Inc0.00-1.59m945.54k-----------0.0177-0.01770.00-0.0040.00-------4,668.68---------------------------371.94------
IMAC Holdings Inc0.00-5.63m1.93m2.00---------5.04-5.460.00-1.080.00--0.000.00-166.65-48.88-1,050.71-70.25-------97.63---14.97--------45.27------
Greenbrook TMS Inc75.21m-52.20m2.92m629.00------0.0388-1.20-1.201.72-2.711.33--8.73---93.25-68.51-206.71-106.4528.2738.65-70.09-76.82---1.9920.04--10.4228.2644.21---54.79--
Data as of Nov 06 2024. Currency figures normalised to QHSLab Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.